| scholarly article | Q13442814 |
| P50 | author | Roberto Bolli | Q56166630 |
| P2093 | author name string | Ning Chen | |
| Wei Tan | |||
| Li Luo | |||
| Buddhadeb Dawn | |||
| Xiaoping Zhu | |||
| Qianhong Li | |||
| Yiru Guo | |||
| Qinghui Ou | |||
| Wen-Jian Wu | |||
| Fangping Yuan | |||
| Gregory N Hunt | |||
| P2860 | cites work | Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences | Q40258000 |
| Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene | Q40662320 | ||
| Gene Therapy With Inducible Nitric Oxide Synthase Protects Against Myocardial Infarction via a Cyclooxygenase-2–Dependent Mechanism | Q41935847 | ||
| H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene | Q43556487 | ||
| Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha | Q43880892 | ||
| Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression | Q44695348 | ||
| Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy | Q45428897 | ||
| Heme oxygenase-1 pathway is involved in delayed protection induced by heat stress against cardiac ischemia-reperfusion injury | Q45712655 | ||
| AAV vectors and cardiovascular disease: targeting TNF receptor in the heart: clue to way forward with AAV? | Q45872009 | ||
| Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. | Q45977008 | ||
| Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest | Q48356691 | ||
| HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study. | Q51596271 | ||
| Mild exercise training, cardioprotection and stress genes profile. | Q54563988 | ||
| Echocardiographic assessment of left ventricular mass and systolic function in mice | Q72187935 | ||
| Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo | Q73300071 | ||
| Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice | Q74236314 | ||
| Cardioprotection: nitric oxide, protein kinases, and mitochondria | Q79780264 | ||
| HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? | Q80367378 | ||
| Heme oxygenase-1: the "emerging molecule" has arrived | Q28207978 | ||
| Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin | Q28235160 | ||
| Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis | Q28287835 | ||
| The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene | Q30454405 | ||
| The late phase of preconditioning | Q33926118 | ||
| AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. | Q34168942 | ||
| Adeno-associated virus: a key to the human genome? | Q34459999 | ||
| Adeno-associated virus vectors can be efficiently produced without helper virus | Q34479933 | ||
| The late phase of preconditioning and its natural clinical application--gene therapy | Q34633367 | ||
| Pharmacological and clinical aspects of heme oxygenase | Q34759206 | ||
| Ischemic preconditioning. Experimental facts and clinical perspective. | Q35021556 | ||
| Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector. | Q35096367 | ||
| Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo | Q35525303 | ||
| Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats | Q35835080 | ||
| Targeted integration of adeno-associated virus (AAV) into human chromosome 19 | Q35936149 | ||
| The innate immune response to adenovirus vectors | Q36026547 | ||
| Modulation of ventricular function through gene transfer in vivo | Q36067860 | ||
| Cytoprotective effects of heme oxygenase in acute renal failure | Q36136514 | ||
| Heme oxygenase and the cardiovascular-renal system | Q36144605 | ||
| How many transcription factors does it take to turn on the heme oxygenase-1 gene? | Q36600797 | ||
| Heme oxygenase -1 gene therapy: recent advances and therapeutic applications | Q36789532 | ||
| Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models | Q36806912 | ||
| Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences | Q36829373 | ||
| Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway | Q36845202 | ||
| Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice | Q36952718 | ||
| Demonstration of an early and a late phase of ischemic preconditioning in mice | Q36982103 | ||
| Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway | Q37401916 | ||
| AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS. | Q37622300 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 1367-1377 | |
| P577 | publication date | 2011-07-22 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences | |
| P478 | volume | 106 |
| Q44728568 | Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study |
| Q47895659 | Delayed remote ischemic preconditioning produces an additive cardioprotection to sevoflurane postconditioning through an enhanced heme oxygenase 1 level partly via nuclear factor erythroid 2-related factor 2 nuclear translocation |
| Q40258000 | Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences |
| Q42407527 | Gene transfer of heme oxygenase-1 using an adeno-associated virus serotype 6 vector prolongs cardiac allograft survival |
| Q84732981 | Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of |
| Q92698553 | HO-1 overexpression and underexpression: Clinical implications |
| Q38860810 | Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival |
| Q38823562 | Heme Oxygenases in Cardiovascular Health and Disease |
| Q38262595 | Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology |
| Q31081214 | Inhaled carbon monoxide provides cerebral cytoprotection in pigs |
| Q91433898 | Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1 |
| Q40247945 | Plasma bilirubin values on admission and ventricular remodeling after a first anterior ST-segment elevation acute myocardial infarction. |
| Q36109838 | The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning |
| Q38115527 | Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis |
| Q37174071 | Tongguan Capsule Protects against Myocardial Ischemia and Reperfusion Injury in Mice |
| Q33847244 | Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome |
Search more.